Mesothelioma and Carboplatin
Carboplatin is a chemotherapy drug commonly used in the treatment of various cancers, including peritoneal mesothelioma. Peritoneal mesothelioma is a rare and aggressive cancer that affects the peritoneum, the lining of the abdominal cavity.
Chemotherapy for Peritoneal Mesothelioma:
Peritoneal mesothelioma is often treated with a combination of chemotherapy drugs. Chemotherapy is used to target and kill cancer cells throughout the body, including those that may have spread beyond the primary tumor site.
Carboplatin as a Platinum-Based Chemotherapy:
Carboplatin is a platinum-based chemotherapy drug, and it is part of a class of medications that also includes cisplatin and oxaliplatin. These drugs work by interfering with the DNA in cancer cells, preventing their ability to divide and grow.
Combination Therapy:
Carboplatin is frequently used in combination with other chemotherapy drugs to enhance its effectiveness. Common combinations for peritoneal mesothelioma may include drugs like pemetrexed and sometimes bevacizumab.
Intraperitoneal (IP) Chemotherapy:
In some cases, chemotherapy may be administered directly into the peritoneal cavity, a treatment approach known as intraperitoneal (IP) chemotherapy. This allows for a higher concentration of the drug to reach the cancer cells in the abdominal area.